Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease

Monday, April 20, 2020 1 min read

Key Takeaway: Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease

Full Press Release Details

Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease.